Frank, Rimerman Advisors LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1977560 Palo Alto, CA

Position in VRTX

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,675,470

+$194,297 QoQ

Shares Held

3,373

+1.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#717

of 1,735 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Frank, Rimerman Advisors LLC holds $4,627,199 across 8 Biotechnology names. VRTX ranks #1 (36.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	3,373	$1,675,470
2	ARGX	Argenx SE	649	$602,122
3	RPRX	Royalty Pharma plc	10,493	$588,342
4	IONS	Ionis Pharmaceuticals Inc	5,807	$460,437
5	ALNY	Alnylam Pharmaceuticals, Inc.	1,228	$369,664
6	REGN	Regeneron Pharmaceuticals, Inc.	570	$355,417
7	INCY	Incyte Corp	2,682	$304,031
8	MRNA	Moderna, Inc.	3,880	$271,716

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,675,470	3,373	+1.7%	Shares	Sole	2026-07-27
2026-03-31	$1,481,173	3,317	+1.1%	Shares	Sole	2026-04-29
2025-12-31	$1,487,927	3,282	+5.2%	Shares	Sole	2026-01-15
2025-09-30	$1,221,916	3,120	-3.9%	Shares	Sole	2025-11-04
2025-06-30	$1,445,119	3,246	-8.6%	Shares	Sole	2025-08-11
2025-03-31	$1,721,111	3,550	+8.5%	Shares	Sole	2025-05-12
2024-12-31	$1,317,634	3,272	-38.4%	Shares	Sole	2025-02-10
2024-09-30	$2,468,644	5,308	-0.0%	Shares	Sole	2024-10-24
2024-06-30	$2,488,434	5,309	+44141.7%	Shares	Sole	2024-08-13
2024-03-31	$5,016	12	0.0%	Shares	Sole	2024-05-09
2023-12-31	$4,882	12	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.